Why This Matters: Innovative medicines are engines of economic growth and security but without sustained focus and commitment to the sector, we risk losing future scientific progress.
Summary: David Reddy, Director General of the IFPMA, explains how investing in new, innovative medicines and vaccines is an investment in economic productivity, growth, and security for G7 countries. Learn more about how G7 members like Canada have both the legacy and strategic imperative to be at the forefront of global pharmaceutical innovation